Archive for: Final Rule

  • ORIGINAL ANALYSIS

  • PDF DOWNLOAD

  • EXTERNAL LINK

  • POST

Payment Innovation: Other

CMS Finalizes Hospital Transparency Requirements and Proposes Similar Policies for Certain Health Plans

In the latest response to the President’s Executive Order on Improving Price and Quality Transparency in American Healthcare, the Department of Health and Human Services released two rules related to requiring increased price transparency for hospitals and health plans.

POST

Payment Innovation: Quality Payment Program

CMS Hosts Webinar on the 2020 QPP Final Rule on Nov. 19

CMS will be hosting a webinar on Tuesday, November 19 from 2:00 to 3:30 PM (ET) where they will review major changes to the QPP in the CY 2020 final rule.

POST

Payment Innovation: Quality Payment Program

CMS Updates QPP Resources

CMS uploaded new materials to the QPP Resource Library.

POST

Payment Innovation: Quality Payment Program

CMS Publishes CY 2020 Quality Payment Program Final Rule

CMS released CY 2020 Revisions to Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment Policies [CMS-1715-F and IFC], which includes changes related to Medicare physician payment and the QPP effective for services on January 1, 2020.

POST

Payment Innovation: Regulation

CMS Releases CY 2020 PFS, OPPS and ASC Final Rules

The CY 2020 final rules were released on November 1, 2019.

POST

Prescription Drug: Litigation

Judge Axes Price Disclosure Rule for Drug Ads

  The Trump administration cannot force drug manufacturers to disclose prices in their pharmaceutical ads to consumers, a federal judge ruled Monday.  

EXTERNAL LINK

Prescription Drug: Regulation

CMS Releases Final Part D Rule

On May 16, 2018, CMS released the final Part D and Medicare Advantage rule aimed at lowering drug prices.

POST

Prescription Drug: Regulation

CMS Issues Final Rule on Drug Pricing Transparency

The Centers for Medicare and Medicaid Services (CMS) released the Final Rule on requiring list prices to be included in direct-to-consumer television advertisements for prescription drug that are reimbursable under Medicare or Medicaid. List price is defined as the wholesale acquisition cost (WAC) for a “typical 30-day regimen or for a typical course of treatment”…

EXTERNAL LINK

Prescription Drug: Regulation

CMS Issues Pair of Rules on Line Item Extension Drugs

CMS issues pair of final rules addressing line item extension drugs.

POST

Payment Innovation: Regulation

CMS Releases Final Rule Overhauling Medicare ACO Program

CMS has released its final rule redesigning the Medicare Accountable Care Organization Program.

POST

Insurance Coverage: Regulation

Short-term Plans Final Rule

The Centers for Medicare and Medicaid Services issued a final rule on short-term limited duration plans.

EXTERNAL LINK

Payment Innovation: Regulation

CMS Releases CY 2018 Quality Payment Program (MACRA) Final Rule

Register Today for a Live Webinar – Overview and Analysis of the CY 2018 QPP Final Rule

ORIGINAL ANALYSIS

Payment Innovation: Regulation

Lost Your Bearings in the MACRA Final Rule? M+ Table of Contents Will Help You Find Your Way

Both a standalone TOC and TOC hyperlinked to the Official Federal Register Published Final Rule are available.

ORIGINAL ANALYSIS

Payment Innovation: Quality Payment Program

CMS Posts Slide Decks on MACRA Final Rule

The Centers for Medicare & Medicaid Services (CMS) recently posted a number of slide decks and a webinar recording on the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015 final rule.

ORIGINAL ANALYSIS

Load more
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope